메뉴 건너뛰기




Volumn 68, Issue 10, 2019, Pages 1801-1812

Microbiota fermentation-NLRP3 axis shapes the impact of dietary fibres on intestinal inflammation

Author keywords

chronic ulcerative colitis; inflammatory bowel disease

Indexed keywords

3 HYDROXYBUTYRIC ACID; BUTYRIC ACID; CELLULOSE; CRYOPYRIN; INTERLEUKIN 10; INTERLEUKIN 10 RECEPTOR ALPHA; INTERLEUKIN 1BETA; INULIN; METRONIDAZOLE; PECTIN; TRIBUTYRIN;

EID: 85060618269     PISSN: 00175749     EISSN: 14683288     Source Type: Journal    
DOI: 10.1136/gutjnl-2018-316250     Document Type: Article
Times cited : (176)

References (55)
  • 1
    • 85024387670 scopus 로고    scopus 로고
    • Fine-mapping infammatory bowel disease loci to single-variant resolution
    • Huang H, Fang M, Jostins L, et al. Fine-mapping infammatory bowel disease loci to single-variant resolution. Nature 2017;547:173-8.
    • (2017) Nature , vol.547 , pp. 173-178
    • Huang, H.1    Fang, M.2    Jostins, L.3
  • 2
    • 79959216005 scopus 로고    scopus 로고
    • Genetics and pathogenesis of infammatory bowel disease
    • Khor B, Gardet A, Xavier RJ. Genetics and pathogenesis of infammatory bowel disease. Nature 2011;474:307-17.
    • (2011) Nature , vol.474 , pp. 307-317
    • Khor, B.1    Gardet, A.2    Xavier, R.J.3
  • 3
    • 84975221149 scopus 로고    scopus 로고
    • Microbiota-inducible innate immune, Siderophore Binding Protein lipocalin 2 is critical for intestinal Homeostasis
    • Singh V, Yeoh BS, Chassaing B, et al. Microbiota-inducible innate immune, Siderophore Binding Protein lipocalin 2 is critical for intestinal Homeostasis. Cell Mol Gastroenterol Hepatol 2016;2:482-98.
    • (2016) Cell Mol Gastroenterol Hepatol , vol.2 , pp. 482-498
    • Singh, V.1    Yeoh, B.S.2    Chassaing, B.3
  • 4
    • 84944447464 scopus 로고    scopus 로고
    • Proneness of tlr5 defcient mice to develop colitis is microbiota dependent
    • Singh V, Yeoh BS, Carvalho F, et al. Proneness of tlr5 defcient mice to develop colitis is microbiota dependent. Gut Microbes 2015;6:279-83.
    • (2015) Gut Microbes , vol.6 , pp. 279-283
    • Singh, V.1    Yeoh, B.S.2    Carvalho, F.3
  • 5
    • 84859862381 scopus 로고    scopus 로고
    • Cytosolic fagellin receptor nlrc4 protects mice against mucosal and systemic challenges
    • Carvalho FA, Nalbantoglu I, Aitken JD, et al. Cytosolic fagellin receptor nlrc4 protects mice against mucosal and systemic challenges. Mucosal Immunol 2012;5:288-98.
    • (2012) Mucosal Immunol , vol.5 , pp. 288-298
    • Carvalho, F.A.1    Nalbantoglu, I.2    Aitken, J.D.3
  • 6
    • 84857049212 scopus 로고    scopus 로고
    • Interleukin-1β (il-1β) promotes susceptibility of toll-like receptor 5 (tlr5) defcient mice to colitis
    • Carvalho FA, Nalbantoglu I, Ortega-Fernandez S, et al. Interleukin-1β (il-1β) promotes susceptibility of toll-like receptor 5 (tlr5) defcient mice to colitis. Gut 2012;61:373-84.
    • (2012) Gut , vol.61 , pp. 373-384
    • Carvalho, F.A.1    Nalbantoglu, I.2    Ortega-Fernandez, S.3
  • 7
    • 77956128040 scopus 로고    scopus 로고
    • Colitis induced in mice with dextran sulfate sodium (DSS) is mediated by the nlrP3 infammasome
    • Bauer C, Duewell P, Mayer C, et al. Colitis induced in mice with dextran sulfate sodium (DSS) is mediated by the nlrP3 infammasome. Gut 2010;59:1192-9.
    • (2010) Gut , vol.59 , pp. 1192-1199
    • Bauer, C.1    Duewell, P.2    Mayer, C.3
  • 8
    • 77950002937 scopus 로고    scopus 로고
    • The nlrP3 infammasome protects against loss of epithelial integrity and mortality during experimental colitis
    • Zaki MH, Boyd KL, Vogel P, et al. The nlrP3 infammasome protects against loss of epithelial integrity and mortality during experimental colitis. Immunity 2010;32:379-91.
    • (2010) Immunity , vol.32 , pp. 379-391
    • Zaki, M.H.1    Boyd, K.L.2    Vogel, P.3
  • 9
    • 77952303410 scopus 로고    scopus 로고
    • The nlrP3 infammasome functions as a negative regulator of tumorigenesis during colitis-associated cancer
    • Allen IC, Tekippe EM, Woodford RM, et al. The nlrP3 infammasome functions as a negative regulator of tumorigenesis during colitis-associated cancer. J Exp Med 2010;207:1045-56.
    • (2010) J Exp Med , vol.207 , pp. 1045-1056
    • Allen, I.C.1    Tekippe, E.M.2    Woodford, R.M.3
  • 10
    • 85006152635 scopus 로고    scopus 로고
    • Nlrp3 infammasome has a protective effect against oxazolone-induced colitis: A possible role in ulcerative colitis
    • Itani S, Watanabe T, Nadatani Y, et al. Nlrp3 infammasome has a protective effect against oxazolone-induced colitis: a possible role in ulcerative colitis. Sci Rep 2016;6:39075.
    • (2016) Sci Rep , vol.6 , pp. 39075
    • Itani, S.1    Watanabe, T.2    Nadatani, Y.3
  • 11
    • 85027693631 scopus 로고    scopus 로고
    • The Pathogenic role of nlrP3 infammasome activation in infammatory bowel diseases of both mice and humans
    • Liu L, Dong Y, Ye M, et al. The Pathogenic role of nlrP3 infammasome activation in infammatory bowel diseases of both mice and humans. J Crohns Colitis 2017;11:737-50.
    • (2017) J Crohns Colitis , vol.11 , pp. 737-750
    • Liu, L.1    Dong, Y.2    Ye, M.3
  • 12
    • 84906247578 scopus 로고    scopus 로고
    • Infammasome activation has an important role in the development of spontaneous colitis
    • Zhang J, Fu S, Sun S, et al. Infammasome activation has an important role in the development of spontaneous colitis. Mucosal Immunol 2014;7:1139-50.
    • (2014) Mucosal Immunol , vol.7 , pp. 1139-1150
    • Zhang, J.1    Fu, S.2    Sun, S.3
  • 13
    • 85019583462 scopus 로고    scopus 로고
    • Activation of nlrP3 infammasome in infammatory Bowel Disease: Differences between Crohn's Disease and Ulcerative colitis
    • Lazaridis LD, Pistiki A, Giamarellos-Bourboulis EJ, et al. Activation of nlrP3 infammasome in infammatory Bowel Disease: Differences Between crohn's Disease and Ulcerative colitis. Dig Dis Sci 2017;62:2348-56.
    • (2017) Dig Dis Sci , vol.62 , pp. 2348-2356
    • Lazaridis, L.D.1    Pistiki, A.2    Giamarellos-Bourboulis, E.J.3
  • 14
    • 85018784717 scopus 로고    scopus 로고
    • Anti-infammatory effect of il-10 mediated by metabolic reprogramming of macrophages
    • Ip WKE, Hoshi N, Shouval DS, et al. Anti-infammatory effect of il-10 mediated by metabolic reprogramming of macrophages. Science 2017;356:513-9.
    • (2017) Science , vol.356 , pp. 513-519
    • Ip, W.K.E.1    Hoshi, N.2    Shouval, D.S.3
  • 15
    • 84924356420 scopus 로고    scopus 로고
    • The ketone metabolite β-hydroxybutyrate blocks nlrP3 infammasome-mediated infammatory disease
    • Youm YH, Nguyen KY, Grant RW, et al. The ketone metabolite β-hydroxybutyrate blocks nlrP3 infammasome-mediated infammatory disease. Nat Med 2015;21:263-9.
    • (2015) Nat Med , vol.21 , pp. 263-269
    • Youm, Y.H.1    Nguyen, K.Y.2    Grant, R.W.3
  • 16
    • 85014089976 scopus 로고    scopus 로고
    • Β-Hydroxybutyrate Deactivates neutrophil nlrP3 infammasome to relieve gout Flares
    • Goldberg EL, Asher JL, Molony RD, et al. Β-Hydroxybutyrate Deactivates neutrophil nlrP3 infammasome to relieve gout Flares. Cell Rep 2017;18:2077-87.
    • (2017) Cell Rep , vol.18 , pp. 2077-2087
    • Goldberg, E.L.1    Asher, J.L.2    Molony, R.D.3
  • 17
    • 84855382568 scopus 로고    scopus 로고
    • Butyrate enhancement of inteleukin-1β production via activation of oxidative stress pathways in lipopolysaccharide-stimulated tHP-1 cells
    • Ohira H, Fujioka Y, Katagiri C, et al. Butyrate enhancement of inteleukin-1β production via activation of oxidative stress pathways in lipopolysaccharide-stimulated tHP-1 cells. J Clin Biochem Nutr 2012;50:59-66.
    • (2012) J Clin Biochem Nutr , vol.50 , pp. 59-66
    • Ohira, H.1    Fujioka, Y.2    Katagiri, C.3
  • 18
    • 12244256841 scopus 로고    scopus 로고
    • Butyrate modulates intestinal epithelial cell-mediated neutrophil migration
    • Böcker U, Nebe T, Herweck F, et al. Butyrate modulates intestinal epithelial cell-mediated neutrophil migration. Clin Exp Immunol 2003;131:53-60.
    • (2003) Clin Exp Immunol , vol.131 , pp. 53-60
    • Böcker, U.1    Nebe, T.2    Herweck, F.3
  • 19
    • 85014556268 scopus 로고    scopus 로고
    • Inhibition of nlrP3 infammasome pathway by butyrate improves corneal wound healing in corneal alkali burn
    • Bian F, Xiao Y, Zaheer M, et al. Inhibition of nlrP3 infammasome pathway by butyrate improves corneal wound healing in corneal alkali burn. Int J Mol Sci 2017;18:562.
    • (2017) Int J Mol Sci , vol.18 , pp. 562
    • Bian, F.1    Xiao, Y.2    Zaheer, M.3
  • 20
    • 12444332013 scopus 로고    scopus 로고
    • Topical butyrate improves effcacy of 5-aSa in refractory distal ulcerative colitis: Results of a multicentre trial
    • Vernia P, Annese V, Bresci G, et al. Topical butyrate improves effcacy of 5-aSa in refractory distal ulcerative colitis: results of a multicentre trial. Eur J Clin Invest 2003;33:244-8.
    • (2003) Eur J Clin Invest , vol.33 , pp. 244-248
    • Vernia, P.1    Annese, V.2    Bresci, G.3
  • 21
    • 0036212170 scopus 로고    scopus 로고
    • Butyrate inhibits nF-kappaB activation in lamina propria macrophages of patients with ulcerative colitis
    • Lührs H, Gerke T, Müller JG, et al. Butyrate inhibits nF-kappaB activation in lamina propria macrophages of patients with ulcerative colitis. Scand J Gastroenterol 2002;37:458-66.
    • (2002) Scand J Gastroenterol , vol.37 , pp. 458-466
    • Lührs, H.1    Gerke, T.2    Müller, J.G.3
  • 22
    • 0034007264 scopus 로고    scopus 로고
    • Combined oral sodium butyrate and mesalazine treatment compared to oral mesalazine alone in ulcerative colitis: Randomized, double-blind, placebo-controlled pilot study
    • Vernia P, Monteleone G, Grandinetti G, et al. Combined oral sodium butyrate and mesalazine treatment compared to oral mesalazine alone in ulcerative colitis: randomized, double-blind, placebo-controlled pilot study. Dig Dis Sci 2000;45:976-81.
    • (2000) Dig Dis Sci , vol.45 , pp. 976-981
    • Vernia, P.1    Monteleone, G.2    Grandinetti, G.3
  • 23
    • 85026922078 scopus 로고    scopus 로고
    • Sodium butyrate inhibits the nF-kappa B signaling pathway and histone deacetylation, and attenuates experimental colitis in an il-10 independent manner
    • Lee C, Kim BG, Kim JH, et al. Sodium butyrate inhibits the nF-kappa B signaling pathway and histone deacetylation, and attenuates experimental colitis in an il-10 independent manner. Int Immunopharmacol 2017;51:47-56.
    • (2017) Int Immunopharmacol , vol.51 , pp. 47-56
    • Lee, C.1    Kim, B.G.2    Kim, J.H.3
  • 24
    • 0029797691 scopus 로고    scopus 로고
    • Treatment of left-sided ulcerative colitis with butyrate enemas: A controlled trial
    • Steinhart AH, Hiruki T, Brzezinski A, et al. Treatment of left-sided ulcerative colitis with butyrate enemas: a controlled trial. Aliment Pharmacol Ther 1996;10:729-36.
    • (1996) Aliment Pharmacol Ther , vol.10 , pp. 729-736
    • Steinhart, A.H.1    Hiruki, T.2    Brzezinski, A.3
  • 25
    • 84973666361 scopus 로고    scopus 로고
    • The colonic crypt protects stem cells from microbiota-derived metabolites
    • Kaiko GE, Ryu SH, Koues OI, et al. The colonic crypt protects stem cells from microbiota-derived metabolites. Cell 2016;165:1708-20.
    • (2016) Cell , vol.165 , pp. 1708-1720
    • Kaiko, G.E.1    Ryu, S.H.2    Koues, O.I.3
  • 26
    • 84973342043 scopus 로고    scopus 로고
    • Accelerated dysbiosis of gut microbiota during aggravation of DSS-induced colitis by a butyrate-producing bacterium
    • Zhang Q, Wu Y, Wang J, et al. Accelerated dysbiosis of gut microbiota during aggravation of DSS-induced colitis by a butyrate-producing bacterium. Sci Rep 2016;6:27572.
    • (2016) Sci Rep , vol.6 , pp. 27572
    • Zhang, Q.1    Wu, Y.2    Wang, J.3
  • 27
    • 84878715402 scopus 로고    scopus 로고
    • Dietary choice affects Shiga toxin-producing Escherichia coli (Stec) O157:H7 colonization and disease
    • Zumbrun SD, Melton-Celsa AR, Smith MA, et al. Dietary choice affects Shiga toxin-producing escherichia coli (Stec) O157:H7 colonization and disease. Proc Natl Acad Sci USA 2013;110:e2126-e2133.
    • (2013) Proc Natl Acad Sci USA , vol.110 , pp. e2126-e2133
    • Zumbrun, S.D.1    Melton-Celsa, A.R.2    Smith, M.A.3
  • 28
    • 85038876729 scopus 로고    scopus 로고
    • Fiber-mediated nourishment of gut microbiota protects against diet-induced obesity by restoring il-22-mediated colonic health
    • Zou J, Chassaing B, Singh V, et al. Fiber-mediated nourishment of gut microbiota protects against diet-induced obesity by restoring il-22-mediated colonic health. Cell Host Microbe 2018;23:41-53.
    • (2018) Cell Host Microbe , vol.23 , pp. 41-53
    • Zou, J.1    Chassaing, B.2    Singh, V.3
  • 29
    • 0036773030 scopus 로고    scopus 로고
    • Genetic control of il-1beta bioactivity through differential regulation of the il-1 receptor antagonist
    • Vamvakopoulos J, Green C, Metcalfe S. Genetic control of il-1beta bioactivity through differential regulation of the il-1 receptor antagonist. Eur J Immunol 2002;32:2988-96.
    • (2002) Eur J Immunol , vol.32 , pp. 2988-2996
    • Vamvakopoulos, J.1    Green, C.2    Metcalfe, S.3
  • 30
    • 85020038610 scopus 로고    scopus 로고
    • Induction of immune gene expression and infammatory mediator release by commonly used surgical suture materials: An experimental in vitro study
    • Lock AM, Gao R, Naot D, et al. Induction of immune gene expression and infammatory mediator release by commonly used surgical suture materials: an experimental in vitro study. Patient Saf Surg 2017;11:16.
    • (2017) Patient Saf Surg , vol.11 , pp. 16
    • Lock, A.M.1    Gao, R.2    Naot, D.3
  • 31
    • 45449085405 scopus 로고    scopus 로고
    • Pro-infammatory disequilibrium of the il-1 beta/il-1ra ratio in an experimental model of perinatal brain damages induced by lipopolysaccharide and hypoxia-ischemia
    • Girard S, Kadhim H, Larouche A, et al. Pro-infammatory disequilibrium of the il-1 beta/il-1ra ratio in an experimental model of perinatal brain damages induced by lipopolysaccharide and hypoxia-ischemia. Cytokine 2008;43:54-62.
    • (2008) Cytokine , vol.43 , pp. 54-62
    • Girard, S.1    Kadhim, H.2    Larouche, A.3
  • 32
    • 36849000520 scopus 로고    scopus 로고
    • Deletion of tlr5 results in spontaneous colitis in mice
    • Vijay-Kumar M, Sanders CJ, Taylor RT, et al. Deletion of tlr5 results in spontaneous colitis in mice. J Clin Invest 2007;117:3909-21.
    • (2007) J Clin Invest , vol.117 , pp. 3909-3921
    • Vijay-Kumar, M.1    Sanders, C.J.2    Taylor, R.T.3
  • 33
    • 84980335892 scopus 로고    scopus 로고
    • Bifdobacteria and butyrate-producing colon bacteria: Importance and strategies for their stimulation in the human gut
    • Rivière A, Selak M, Lantin D, et al. Bifdobacteria and butyrate-producing colon bacteria: importance and strategies for their stimulation in the human gut. Front Microbiol 2016;7:979.
    • (2016) Front Microbiol , vol.7 , pp. 979
    • Rivière, A.1    Selak, M.2    Lantin, D.3
  • 34
    • 58849136151 scopus 로고    scopus 로고
    • Reduction of dietary poorly absorbed short-chain carbohydrates (FODMaPs) improves abdominal symptoms in patients with infammatory bowel disease-a pilot study
    • Gearry RB, Irving PM, Barrett JS, et al. Reduction of dietary poorly absorbed short-chain carbohydrates (FODMaPs) improves abdominal symptoms in patients with infammatory bowel disease-a pilot study. J Crohns Colitis 2009;3:8-14.
    • (2009) J Crohns Colitis , vol.3 , pp. 8-14
    • Gearry, R.B.1    Irving, P.M.2    Barrett, J.S.3
  • 35
    • 21044435580 scopus 로고    scopus 로고
    • Personal view: Food for thought-western lifestyle and susceptibility to Crohn's disease. The FODMaP hypothesis
    • Gibson PR, Shepherd SJ. Personal view: food for thought-western lifestyle and susceptibility to crohn's disease. the FODMaP hypothesis. Aliment Pharmacol Ther 2005;21:1399-409.
    • (2005) Aliment Pharmacol Ther , vol.21 , pp. 1399-1409
    • Gibson, P.R.1    Shepherd, S.J.2
  • 36
    • 0033046843 scopus 로고    scopus 로고
    • Inulin and oligofructose: Safe intakes and legal status
    • Coussement PA. Inulin and oligofructose: safe intakes and legal status. J Nutr 1999;129:1412S-7.
    • (1999) J Nutr , vol.129 , pp. 1412S-1417S
    • Coussement, P.A.1
  • 37
    • 84963621752 scopus 로고    scopus 로고
    • Follow-up of patients with functional bowel symptoms treated with a low FODMaP diet
    • Maagaard L, Ankersen D V, Végh Z, et al. Follow-up of patients with functional bowel symptoms treated with a low FODMaP diet. World J Gastroenterol 2016;22:4009-19.
    • (2016) World J Gastroenterol , vol.22 , pp. 4009-4019
    • Maagaard, L.1    Ankersen, D.V.2    Végh, Z.3
  • 38
    • 76149141784 scopus 로고    scopus 로고
    • Evidence-based dietary management of functional gastrointestinal symptoms: The FODMaP approach
    • Gibson PR, Shepherd SJ. Evidence-based dietary management of functional gastrointestinal symptoms: the FODMaP approach. J Gastroenterol Hepatol 2010;25:252-8.
    • (2010) J Gastroenterol Hepatol , vol.25 , pp. 252-258
    • Gibson, P.R.1    Shepherd, S.J.2
  • 39
    • 84904752002 scopus 로고    scopus 로고
    • Ketone body therapy: From the ketogenic diet to the oral administration of ketone ester
    • Hashim SA, Vanitallie TB. Ketone body therapy: from the ketogenic diet to the oral administration of ketone ester. J Lipid Res 2014;55:1818-26.
    • (2014) J Lipid Res , vol.55 , pp. 1818-1826
    • Hashim, S.A.1    Vanitallie, T.B.2
  • 40
    • 33746377279 scopus 로고    scopus 로고
    • Regulatory t cells suppress systemic and mucosal immune activation to control intestinal infammation
    • Izcue A, Coombes JL, Powrie F. Regulatory t cells suppress systemic and mucosal immune activation to control intestinal infammation. Immunol Rev 2006;212:256-71.
    • (2006) Immunol Rev , vol.212 , pp. 256-271
    • Izcue, A.1    Coombes, J.L.2    Powrie, F.3
  • 41
    • 84994631224 scopus 로고    scopus 로고
    • Prevalence of infammatory Bowel Disease among adults aged ≥18 Years-United States, 2015
    • Dahlhamer JM, Zammitti E P, Ward BW, et al. Prevalence of infammatory Bowel Disease among adults aged ≥18 Years-United States, 2015. MMWR Morb Mortal Wkly Rep 2016;65:1166-9.
    • (2016) MMWR Morb Mortal Wkly Rep , vol.65 , pp. 1166-1169
    • Dahlhamer, J.M.1    Zammitti, E.P.2    Ward, B.W.3
  • 42
    • 84866549438 scopus 로고    scopus 로고
    • Dysfunction of the intestinal microbiome in infammatory bowel disease and treatment
    • Morgan XC, Tickle TL, Sokol H, et al. Dysfunction of the intestinal microbiome in infammatory bowel disease and treatment. Genome Biol 2012;13:r79.
    • (2012) Genome Biol , vol.13 , pp. r79
    • Morgan, X.C.1    Tickle, T.L.2    Sokol, H.3
  • 43
    • 84893029775 scopus 로고    scopus 로고
    • Increased proportions of Bifdobacterium and the lactobacillus group and loss of butyrate-producing bacteria in infammatory bowel disease
    • Wang W, Chen L, Zhou R, et al. Increased proportions of Bifdobacterium and the lactobacillus group and loss of butyrate-producing bacteria in infammatory bowel disease. J Clin Microbiol 2014;52:398-406.
    • (2014) J Clin Microbiol , vol.52 , pp. 398-406
    • Wang, W.1    Chen, L.2    Zhou, R.3
  • 44
    • 79955579989 scopus 로고    scopus 로고
    • The microbiome and butyrate regulate energy metabolism and autophagy in the mammalian colon
    • Donohoe DR, Garge N, Zhang X, et al. The microbiome and butyrate regulate energy metabolism and autophagy in the mammalian colon. Cell Metab 2011;13:517-26.
    • (2011) Cell Metab , vol.13 , pp. 517-526
    • Donohoe, D.R.1    Garge, N.2    Zhang, X.3
  • 45
    • 84890550163 scopus 로고    scopus 로고
    • Metabolites produced by commensal bacteria promote peripheral regulatory t-cell generation
    • Arpaia N, Campbell C, Fan X, et al. Metabolites produced by commensal bacteria promote peripheral regulatory t-cell generation. Nature 2013;504:451-5.
    • (2013) Nature , vol.504 , pp. 451-455
    • Arpaia, N.1    Campbell, C.2    Fan, X.3
  • 46
    • 84890564250 scopus 로고    scopus 로고
    • Commensal microbe-derived butyrate induces the differentiation of colonic regulatory t cells
    • Furusawa Y, Obata Y, Fukuda S, et al. Commensal microbe-derived butyrate induces the differentiation of colonic regulatory t cells. Nature 2013;504:446-50.
    • (2013) Nature , vol.504 , pp. 446-450
    • Furusawa, Y.1    Obata, Y.2    Fukuda, S.3
  • 47
    • 84881068658 scopus 로고    scopus 로고
    • The microbial metabolites, short-chain fatty acids, regulate colonic treg cell homeostasis
    • Smith PM, Howitt MR, Panikov N, et al. The microbial metabolites, short-chain fatty acids, regulate colonic treg cell homeostasis. Science 2013;341:569-73.
    • (2013) Science , vol.341 , pp. 569-573
    • Smith, P.M.1    Howitt, M.R.2    Panikov, N.3
  • 48
    • 77954907393 scopus 로고    scopus 로고
    • Manipulation of dietary short chain carbohydrates alters the pattern of gas production and genesis of symptoms in irritable bowel syndrome
    • Ong DK, Mitchell SB, Barrett JS, et al. Manipulation of dietary short chain carbohydrates alters the pattern of gas production and genesis of symptoms in irritable bowel syndrome. J Gastroenterol Hepatol 2010;25:1366-73.
    • (2010) J Gastroenterol Hepatol , vol.25 , pp. 1366-1373
    • Ong, D.K.1    Mitchell, S.B.2    Barrett, J.S.3
  • 49
    • 84894254680 scopus 로고    scopus 로고
    • Wild-type and il10-null mice have differential colonic epithelial gene expression responses to dietary supplementation with synbiotic Bifdobacterium animalis subspecies lactis and inulin
    • Kuo SM, Chan WC, Hu Z. Wild-type and il10-null mice have differential colonic epithelial gene expression responses to dietary supplementation with synbiotic Bifdobacterium animalis subspecies lactis and inulin. J Nutr 2014;144:245-51.
    • (2014) J Nutr , vol.144 , pp. 245-251
    • Kuo, S.M.1    Chan, W.C.2    Hu, Z.3
  • 50
    • 53049093860 scopus 로고    scopus 로고
    • Inulin results in increased levels of beta-catenin and cyclin D1 as the adenomas increase in size from small to large in the Min/+ mouse
    • Misikangas M, Tanayama H, Rajakangas J, et al. Inulin results in increased levels of beta-catenin and cyclin D1 as the adenomas increase in size from small to large in the Min/+ mouse. Br J Nutr 2008;99:963-70.
    • (2008) Br J Nutr , vol.99 , pp. 963-970
    • Misikangas, M.1    Tanayama, H.2    Rajakangas, J.3
  • 51
    • 0041464523 scopus 로고    scopus 로고
    • Promotion of intestinal tumor formation by inulin is associated with an accumulation of cytosolic beta-catenin in Min mice
    • Pajari AM, Rajakangas J, Päivärinta E, et al. Promotion of intestinal tumor formation by inulin is associated with an accumulation of cytosolic beta-catenin in Min mice. Int J Cancer 2003;106:653-60.
    • (2003) Int J Cancer , vol.106 , pp. 653-660
    • Pajari, A.M.1    Rajakangas, J.2    Päivärinta, E.3
  • 52
    • 84962022192 scopus 로고    scopus 로고
    • Chronically elevated levels of short-chain fatty acids induce t cell-mediated ureteritis and hydronephrosis
    • Park J, Goergen CJ, Hogenesch H, et al. Chronically elevated levels of short-chain fatty acids induce t cell-mediated ureteritis and hydronephrosis. J Immunol 2016;196:2388-400.
    • (2016) J Immunol , vol.196 , pp. 2388-2400
    • Park, J.1    Goergen, C.J.2    Hogenesch, H.3
  • 53
    • 84922163095 scopus 로고    scopus 로고
    • Short-chain fatty acids induce both effector and regulatory t cells by suppression of histone deacetylases and regulation of the mtOr-S6K pathway
    • Park J, Kim M, Kang SG, et al. Short-chain fatty acids induce both effector and regulatory t cells by suppression of histone deacetylases and regulation of the mtOr-S6K pathway. Mucosal Immunol 2015;8:80-93.
    • (2015) Mucosal Immunol , vol.8 , pp. 80-93
    • Park, J.1    Kim, M.2    Kang, S.G.3
  • 54
    • 85021290293 scopus 로고    scopus 로고
    • Supplementation of low-and high-fat diets with fermentable fber exacerbates severity of DSS-induced acute colitis
    • Miles J P, Zou J, Kumar M V, et al. Supplementation of low-and high-fat diets with fermentable fber exacerbates severity of DSS-induced acute colitis. Infamm Bowel Dis 2017;23:1133-43.
    • (2017) Infamm Bowel Dis , vol.23 , pp. 1133-1143
    • Miles, J.P.1    Zou, J.2    Kumar, M.V.3
  • 55
    • 0030703162 scopus 로고    scopus 로고
    • Metronidazole. a therapeutic review and update
    • Freeman CD, Klutman NE, Lamp KC. Metronidazole. a therapeutic review and update. Drugs 1997;54:679-708.
    • (1997) Drugs , vol.54 , pp. 679-708
    • Freeman, C.D.1    Klutman, N.E.2    Lamp, K.C.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.